Skip to Content

VICC to Host NCCN 2012 Congress Series

July 11, 2012

Earn up to 5.5 continuing education credits!

Program Overview:
This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This congress will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Intended Audience:
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Hosted by: Vanderbilt-Ingram Cancer Center

Date: Friday, July 20, 2012
8 a.m. – 3:15 p.m.
(Registration and Exhibits begins at 7:15 a.m.)
Register online for this event.

Place: Gaylord Springs Golf Links
18 Springhouse Lane
Clubhouse (2nd Floor)
Nashville, Tennessee 37214

Fee: $49 for Physicians, Nurses, Pharmacists, and other Health Care Professionals
$495 for Industry


  • 7:15 – 8 a.m. Registration and Exhibits
  • 8 – 8:10 a.m. Welcome
    Peter E. Clark, M.D.
    Vanderbilt-Ingram Cancer Center


  • 8:10 – 8:55 a.m. Surgical Management of Localized Kidney Cancer and Resectable Advanced Disease
    Sam S. Chang, M.D.
    Vanderbilt-Ingram Cancer Center
  • 9 – 9:45 a.m. Targeted Therapy Options in Unresectable and Recurrent Kidney Cancer
    Toni K. Choueiri, M.D.
    Dana-Farber/Brigham and Women’s Cancer Center
  • 9:45 – 10:05 a.m. Break and Exhibits


  • 10:05 – 11 a.m. Treatment of Non-Metastatic Bladder Cancer
    Peter E. Clark, M.D.
    Vanderbilt-Ingram Cancer Center
  • 11:05 – 11:50 a.m. Treatment of Advanced Bladder Cancer
    Lance C. Pagliaro, M.D.
    The University of Texas MD Anderson Cancer Center
  • 11:50 a.m. – 12:50 p.m. Lunch and Exhibits


  • 12:50 – 1:35 p.m. Risk Assessment for Locoregional Prostate Cancer
    James L. Mohler, M.D.
    Roswell Park Cancer Institute
  • 1:40 – 2:25 p.m. Treatment of Advanced Prostate Cancer
    Sandy Srinivas, M.D.
    Stanford Cancer Institute
  • 2:30 – 3:15 p.m. Radiation Therapy in Prostate Cancer
    Michael Kuettel, M.D., M.B.A., Ph.D.
    Roswell Park Cancer Institute
  • 3:15 p.m. Closing Remarks

*Subject to change.

This activity is supported by an educational donation provided by Amgen. This activity is supported by an independent educational grant from Abbott. This activity is supported by educational grants from Astellas, Pfizer, and sanofi-aventis U.S.

This is a knowledge-based activity.